Evidence map›Paper›PMID 40872848›Full record

ArticleViruses2025

Disseminated Varicella-Zoster Virus Infection with Internal Organ Involvement: A Scoping Review of 156 Cases.

Aleksandar Timotijevic, Pratyusha Kodela, Vladislav Glušac, Sara Bokonjic, Bojan Joksimovic, Juan Vera Gomez, David Ladin, Igor Dumic

Abstract readScoping Review
In one paragraph

Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Varicella-Zoster Virus-Associated Esophagogastritis.Case reports in gastrointestinal medicine · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aleksandar TimotijevicDepartment of Hospital Medicine, Mayo Clinic Health System, Eau Claire, WI 54703, USA.
Pratyusha KodelaDepartment of Hospital Medicine, Mayo Clinic Health System, Eau Claire, WI 54703, USA.ORCID 0009-0001-8240-1937
Vladislav GlušacSchool of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Sara BokonjicInstitute of Diagnostic and Interventional Radiology, Medical Faculty and University Hospital, Heinrich Heine University, 40225 Dusseldorf, Germany.ORCID 0009-0005-9563-830X
Bojan JoksimovicDepartment of Pathological Physiology, Faculty of Medicine, University of East Sarajevo, 73300 Foca, Bosnia and Herzegovina.ORCID 0000-0003-3794-2539
Juan Vera GomezDepartment of Hospital Medicine, Mayo Clinic Health System, Eau Claire, WI 54703, USA.
David LadinDepartment of Hospital Medicine, Mayo Clinic Health System, Eau Claire, WI 54703, USA.
Igor DumicDepartment of Hospital Medicine, Mayo Clinic Health System, Eau Claire, WI 54703, USA.ORCID 0000-0002-5312-8812

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Visceral disseminated varicella-zoster virus infection (VD-VZV) involves the hematogenous spread of VZV from the skin to the internal organs. Though rare, it is potentially life-threatening, predominantly affecting immunocompromised individuals. Diagnosis is often delayed due to nonspecific symptoms mimicking other viral illnesses. While the vesicular rash is a hallmark sign, it is absent in approximately 5% of cases. Visceral involvement may precede cutaneous lesions, complicate early recognition, and increase the risk of severe complications. This scoping review screened 594 articles of which 153 met the inclusion criteria, yielding 156 individual cases. Patients were predominantly male (53.8%), with a mean age of 42.3 years. The overall mortality rate was 25.0%. Multiple organs were involved in 46.1% of cases. The most frequently affected were the lungs (56%), liver (44%), heart (16%), kidneys (11%), pancreas (11%), stomach (10%), and esophagus (6%). Antivirals were administered in 89.1% of cases, while corticosteroids were used in 22.4%, with no significant impact on outcomes. Early diagnosis, achieved in 65.4% of patients, was significantly associated with survival (

Indexed as

Herpesvirus 3, HumanHerpes ZosterVaricella Zoster Virus InfectionAdultAgedAntiviral AgentsFemaleHumansImmunocompromised HostMaleMiddle AgedAntiviral Agentssplenomegalyvaricella hepatitisvaricella myocarditisvaricella pneumoniavaricella-zoster virusvisceral involvementvisceral VZV infectionVZV pancreatitis

Identifiers

PMID40872848
PMCPMC12390662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.